| View |
|
DRP-14439
|
Gliclazide
|
Glucor MR 60
|
60 mg
|
Modified Release Tablet
|
-
|
Stallion Laboratories Pvt. Ltd
|
India
|
Initial
|
17 October 2023
|
17 October 2028
|
| View |
|
DRP-14584
|
Diosmin + Hesperidin
|
Venoright
|
450 mg/50 mg
|
Film-Coated Tablet
|
Vasoprotective (Capillary Stabilizing Agent)
|
Novagen Healthcare Private Limite
|
India
|
Initial (Correction)
|
15 February 2024
|
18 October 2025
|
| View |
|
DRP-14182
|
Paracetamol + Caffeine + Phenylephrine (as hydrochloride) + Chlorphenamine maleate
|
Parfein
|
500 mg/30 mg/10 mg/2 mg
|
Tablet
|
-
|
Scott-Edil Pharmacia Ltd.
|
India
|
Initial Correction]
|
17 October 2023
|
14 July 2028
|
| View |
|
DRP-14560
|
Potassium Chloride
|
Clorsium
|
600 mg
|
Film-Coated Tablet
|
-
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial
|
13 October 2023
|
13 October 2028
|
| View |
|
DRP-14555
|
Potassium Chloride
|
Citrine
|
750 mg
|
Sustained Release Tablet
|
-
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial
|
12 October 2023
|
12 October 2028
|
| View |
|
DRP-14557
|
Pemetrexed (as disodium heptahydrate)
|
Trepexed-100
|
100 mg
|
Lyophilized Powder for IV Infusion
|
-
|
Admac Lifesciences
|
India
|
Initial
|
13 October 2023
|
13 October 2028
|
| View |
|
DRP-14559
|
Etoricoxib
|
None
|
30 mg
|
Film-Coated Tablet
|
-
|
USV Private Limited
|
India
|
Initial
|
13 October 2023
|
13 October 2028
|
| View |
|
DRP-14558
|
Etoricoxib
|
None
|
90 mg
|
Film-Coated Tablet
|
-
|
USV Private Limited
|
India
|
Initial
|
13 October 2023
|
13 October 2028
|
| View |
|
DRP-12702-02
|
Rosuvastatin (as Calcium)
|
Rosunav
|
10 mg
|
Film-Coated Tablet
|
-
|
Pharmevo (Pvt) Limited
|
Pakistan
|
CLIDP Conversion
|
15 February 2023
|
11 May 2025
|
| View |
|
DRP-11270-01
|
Miconazole Nitrate
|
None
|
20 mg/g (2% w/w)
|
Topical Cream
|
Antifungal (Imidazole)
|
KLM Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
08 November 2022
|
22 February 2027
|
| View |
|
DRP-11565
|
Propofol
|
None
|
10 mg/mL (200 mg/20 mL)
|
Emulsion for Injection (IV)
|
General Anesthetic
|
Aspiro Pharma Limited
|
India
|
Initial
|
30 March 2022
|
30 March 2027
|
| View |
|
DRP-10475-05
|
Telmisartan
|
OP-Telmis
|
40 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
02 August 2023
|
30 September 2026
|
| View |
|
DRP-12509-01
|
Vitamin B1 + B6 + B12
|
OP-Regenerv
|
300 mg/ 300 mg/ 1 mg
|
Capsule
|
Vitamin
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
10 August 2023
|
25 August 2027
|
| View |
DRP-11848-04_PI_01.pdf
|
DRP-11848-04
|
Sitagliptin (as phosphate monohydrate) + Metformin Hydrochloride
|
Xiglip M
|
50 mg/ 500 mg
|
Film-Coated Tablet
|
-
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
03 July 2023
|
10 May 2027
|
| View |
|
DRP-11848-05
|
Sitagliptin (as phosphate monohydrate) + Metformin Hydrochloride
|
OP-Sita Duo
|
50 mg/ 500 mg
|
Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
02 August 2023
|
10 May 2027
|
| View |
|
DRP-11880-01
|
Atorvastatin (as calcium)
|
OP-Ator
|
20 mg
|
Film-Coated Tablet
|
HMG CoA Reductase Inhibitor
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
01 August 2023
|
18 May 2027
|
| View |
|
DRP-12411-05
|
Sevelamer carbonate
|
Fosfamer
|
800 mg
|
Film-Coated Tablet
|
-
|
Stallion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
19 April 2023
|
03 August 2027
|
| View |
|
DRP-12411-03
|
Sevelamer carbonate
|
Rinosever
|
800 mg
|
Film-Coated Tablet
|
-
|
Stallion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
06 March 2023
|
03 August 2027
|
| View |
|
DRP-12411-02
|
Sevelamer carbonate
|
Verlaserv
|
800 mg
|
Film-Coated Tablet
|
Phosphate Binder
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
11 January 2023
|
03 August 2027
|
| View |
|
DRP-12411-04
|
Sevelamer carbonate
|
Sevelaget
|
800 mg
|
Film-Coated Tablet
|
-
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
07 March 2023
|
03 August 2027
|